Live Breaking News & Updates on Alzheimer 39s Disease

Stay updated with breaking news from Alzheimer 39s disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Can supplements really help prevent dementia?

A growing number of nutritional supplements claim to reduce our risk of developing dementia – but is there any evidence that they work? ....

United Kingdom , Rush University , United States , Louise Newson , Claudia Cooper , Alzheimer Society , University Of Exeter , Iowa State University , Neurodegeneration Policy Research Unit De , Queen Mary University Of London , Queen Mary University , Neurodegeneration Policy Research Unit , Charlotte Faure , Health And Fitness , Evergreen Health , Nutrition And Dieting , Alzheimer 39s Disease ,

EISAI TO PRESENT DATA ON LECANEMAB and OTHER ALZHEIMER'S DISEASE RESEARCH AT THE AD/PD™ 2024 ANNUAL MEETING

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (U.S. brand name: LEQEMBI®), Eisai's anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer's disease (AD), at the 2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD™) from March 5-9 in Lisbon, Portugal, and virtually. The lecanemab data and additional research findings from Eis ....

United Kingdom , Great Britain , Robert Perneczky , Sysmex Eisai , Jeffrey Cummings , Miia Kivipelto , Lynn Kramer , Bioarctic Eisai , Ministry Of Health , Alzheimer Clinical Trial Consortium , National Institutes Of Health , Asset In Development , Washington University School Of Medicine , Critical Path For Alzheimer Disease Consortium , National Institute On , Ad Cooperative Study , Biomarkers In Predicting Amyloid Positivity Community , Drug Administration , Eisai Inc , Clinical Research At Eisai Inc , Alzheimer Network Trials Unit , Shimadzu Oita University Eisai , Deputy Chief Clinical Officer , Senior Vice President , Clinical Research , Chief Clinical Officer ,

Ask Dr James: What else might be the cause of my failing memory?

In his new column, Dr James Le Fanu answers readers’ questions. This week: what could be causing this reader’s lapses in memory ....

City Of , United Kingdom , Los Angeles , United States , Peter Nestor , Jan Coebergh , Le Fanu , Queensland Brain Institute , Cambridge University , Cardiology Department At St Mary Hospital , Royal London Hospital , Renal Transplant Unit , Royal Free , Cardiology Department , Sunday Telegraph , Modern Medicine , Los Angeles Times Book , Professor Peter Nestor , Health And Fitness , Alzheimer 39s Disease , Elder Health , Us Content ,

Alzheimer's disease (AD): Tackling neuroinflammation for early intervention and enhanced treatments

This article talks about neuroinflammation being a crucial aspect of Alzheimer's disease (AD). It explores various targets such as microglia, amyloid and tau, to develop more effective treatments and the importance of early intervention. ....

Charles River , United States , Norra Savolax , Rudolph Tanzi , Dan Rocca , Research Leader At Charles River Laboratories , University Of London , Research Unit At Massachusetts , Aging Research Unit , Massachusetts General Hospital , Image Credit , Research Leader , Charles River Laboratories , Senior Manager , Content Policy , News Medical Net , Alzheimer 39s Disease ,

Researchers discover mechanism to reverse amyloid plaque assembly in Alzheimer's disease

University of North Carolina at Chapel Hill researchers have developed a new drug delivery platform that harnesses helical amyloid fibers designed to untwist and release drugs in response to body temperatures. ....

Ronit Freeman , Emory University , University Of North Carolina At Chapel Hill , Nature Communications , North Carolina , Chapel Hill , Alzheimer 39s Disease , Drug Delivery ,